Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation
暂无分享,去创建一个
Haruhisa Inoue | F. Gallyas | O. Ueda | Hiroshi Suzuki | T. Tabira | F. Checler | H. Inoue | Kazuharu Ozawa | Takeshi Tabira | De-Hua Chui | Hiroshi Tanahashi | Sachiya Ikeda | Frédéric Checler | Otoya Ueda | Hiroshi Suzuki | Wataru Araki | Keiro Shirotani | Keikichi Takahashi | Ferenc Gallyas | W. Araki | K. Ozawa | D. Chui | K. Shirotani | H. Tanahashi | Keikichi Takahashi | S. Ikeda
[1] A. Paetau,et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1 , 1998, Nature Medicine.
[2] B. Hyman,et al. APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1 , 1997, Journal of neuropathology and experimental neurology.
[3] T. Tabira,et al. Immunohistochemical study of Alzheimer's disease using antibodies to synthetic amyloid and fibronectin , 1988, Journal of the Neurological Sciences.
[4] D. Borchelt,et al. Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins , 1997, Neuron.
[5] Takashi Asada,et al. Familial Alzheimer's disease genes in Japanese , 1998, Journal of the Neurological Sciences.
[6] T. Tabira,et al. Stress induces neuronal death in the hippocampus of castrated rats , 1992, Neuroscience Letters.
[7] Hans Clevers,et al. Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis , 1998, Nature.
[8] C. Haass,et al. Proteolytic processing of Alzheimer's disease associated proteins. , 1998, Journal of neural transmission. Supplementum.
[9] J. Hardy,et al. The presenilins and Alzheimer's disease. , 1997, Human molecular genetics.
[10] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.
[11] John Hardy,et al. Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.
[12] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[13] C. van Broeckhoven,et al. Presenilin mutations in Alzheimer's disease , 1998, Human mutation.
[14] T. Sunderland,et al. Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation , 1996, Science.
[15] Weiming Xia,et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.
[16] T. Tabira,et al. Both N‐terminal and C‐terminal fragments of Presenilin 1 colocalize with neurofibrillary tangles in neurons and dystrophic neurites of senile plaques in Alzheimer's disease , 1998, Journal of neuroscience research.
[17] J. Hardy,et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.
[18] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[19] B. Sommer,et al. Neuron loss in APP transgenic mice , 1998, Nature.
[20] M. Jacquin,et al. Neuronal and Glial Apoptosis after Traumatic Spinal Cord Injury , 1997, The Journal of Neuroscience.
[21] T. Tabira,et al. Decreased beta-amyloid and increased abnormal Tau deposition in the brain of aged patients with leprosy. , 1994, The American journal of pathology.
[22] J. Hardy,et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes , 1998, Nature Medicine.
[23] G. Buzsáki,et al. Four modified silver methods for thick sections of formaldehyde-fixed mammalian central nervous tissue: ‘dark’ neurons, perikarya of all neurons, microglial cells and capillaries , 1993, Journal of Neuroscience Methods.
[24] Bruce A. Yankner,et al. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity , 1998, Nature Medicine.
[25] M. Mattson,et al. Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.
[26] N. Robakis,et al. Alzheimer's disease: a re-examination of the amyloid hypothesis , 1998, Trends in Neurosciences.
[27] J. Buxbaum,et al. Characterization of New Polyclonal Antibodies Specific for 40 and 42 Amino Acid-Long Amyloid β Peptides: Their Use to Examine the Cell Biology of Presenilins and the Immunohistochemistry of Sporadic Alzheimer’s Disease and Cerebral Amyloid Angiopathy Cases , 1997, Molecular medicine.
[28] Kenneth S. Kosik,et al. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology , 1996, Nature Medicine.
[29] Allan I. Levey,et al. Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.